Holds one active US DMF for heparin, filing since 1976. Its 2019 FDA inspection closed as NAI, and its GMP is recognised in 18 markets.
Holds one active US DMF for heparin, filing since 2012. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for heparin, filing since 1985. Its 2021 FDA inspection closed as VAI.
Holds one active US DMF for heparin, filing since 2020.
Holds one active US DMF and one valid CEP for heparin, filing since 1976. Its 2025 FDA inspection closed as OAI.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Heparin manufacturer list to companies based in United States. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free